Every year 1.24 million are diagnosed with the life-threatening disease called “Blood Cancer”. This cancer has three major types of diseases: Leukemia, a cancer in which the bone marrow makes too many blood cells and/or abnormal blood cells; Lymphoma, a neoplasm, in which cancer cells form in the lymphoid organs, and multiple myeloma, a tumor, in which abnormal plasma cells build up in the bone marrow. The signs and symptoms are very general and can often be overlooked. Because treatments for blood cancer have vastly improved over the last several decades, many types of blood cancers are now highly treatable if diagnosed early.

We at Diagnostic BioSystems are committed to advancing science and helping people fight the ever-challenging disease “Cancer”.

DBS’ comprehensive hematologic panel includes novel rabbit monoclonal and mouse monoclonal antibodies. These antibodies ensure sensitivity and specificity of IHC detections. As a result, pathologists and oncologists can have rapid, precise results and an accurate diagnosis to determine an effective treatment for their patients.

CD34: https://bit.ly/DBS-CD34

Tdt: https://bit.ly/DBS-Tdt

CD20: https://bit.ly/DBS-CD20

CD3: https://bit.ly/DBS-CD3

Kappa Light Chain: https://bit.ly/KappaLightChain

Lambda Light Chain: https://bit.ly/LambdaLightChain

Order Now: https://bit.ly/3C1nMSw